Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, Prognosis Impact, and Methotrexate Cytotoxicity.

Asian Pac J Cancer Prev · 2020 · PMC7798150 · PMID 33112552

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

we didn’t find any significant differences between hepatotoxic and non-hepatotoxic patients regarding cyclin D1 genotypes despite a highly significant difference in methotrexate level.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.